Liver Health | Fibrosis Risk
Metabolic Liver & Fatty Liver Assessment
Metabolic Liver & Fatty Liver Assessment
Fat accumulation in the liver is closely linked with metabolic health, particularly obesity, prediabetes and type 2 diabetes. Metabolic Liver & Fatty Liver Assessment at Yoyime Wellness Clinic in Dubai provides a focused pathway for suspected or previously identified metabolic dysfunction associated steatotic liver disease or MASLD. Our clinician reviews metabolic risks, alcohol intake, medicines, liver enzymes and relevant imaging before assessing fibrosis risk. Non-invasive tools such as FIB 4 may guide whether further liver stiffness assessment or specialist hepatology review is appropriate.
Benefits of Metabolic Liver & Fatty Liver Assessment
Assesses Fatty Liver Risk
Evaluates Fibrosis Risk
Guides Liver Follow Up
Recommended for Patients With
Known Fatty Liver
Persistent Liver Enzyme Changes
Metabolic Liver Risk
Step-By-Step Procedure - Metabolic Liver & Fatty Liver Assessment
Liver History
Discuss previous fatty liver findings, liver tests and relevant medical history.
Metabolic Risk Review
Our clinician assesses diabetes, prediabetes, weight and related cardiometabolic factors.
Lifestyle Review
Alcohol intake, medicines, supplements and other potential liver influences are considered.
Laboratory Assessment
Relevant liver enzymes, platelet count and metabolic tests are reviewed or arranged.
Fibrosis Risk
A validated non-invasive fibrosis assessment such as FIB 4 may be calculated where appropriate.
Additional Assessment
Liver imaging or stiffness measurement may be recommended according to risk.
Clinical Interpretation
Results are reviewed to distinguish lower risk patients from those needing further investigation.
Liver Care Direction
Monitoring, metabolic management or specialist referral is recommended according to findings.
Have questions about Metabolic Liver & Fatty Liver Assessment?
Message our team on WhatsApp for personalised guidance before you book.
- Assess metabolic fatty liver and fibrosis risk using appropriate clinical pathways.
- Identify patients needing monitoring, additional liver testing or specialist evaluation early.
Frequently Asked Questions
Metabolic Liver & Fatty Liver Assessment
Yoyime's Metabolic Liver & Fatty Liver Assessment in Dubai provides focused evaluation of suspected MASLD, including metabolic risk, liver findings and assessment of possible fibrosis.
MASLD stands for metabolic dysfunction associated steatotic liver disease and is the newer term used for fatty liver associated with cardiometabolic risk factors.
MASLD has replaced the term nonalcoholic fatty liver disease in current clinical terminology and places greater emphasis on the accompanying cardiometabolic risk profile.
Risk is increased in people with type 2 diabetes, prediabetes, excess adiposity and other cardiometabolic abnormalities.
No. Clinically significant fibrosis can occur even when liver enzyme values are not markedly elevated, which is why risk based assessment can be important.
FIB 4 is a non-invasive fibrosis risk calculation based on age, AST, ALT and platelet count. It is used as an initial tool to help identify people who may require further liver fibrosis assessment.
Depending on the result and individual circumstances, additional assessment with liver stiffness measurement or another validated fibrosis test may be recommended, followed by specialist referral when indicated.
No. Metabolic Health Assessment provides an overall metabolic overview. This service focuses specifically on the liver, hepatic steatosis and fibrosis risk.
Yes. Structured nutrition, physical activity and appropriate weight management are important components of MASLD care, particularly for people with excess weight or metabolic disease.
Cost depends on consultation, laboratory testing and whether imaging or liver stiffness assessment is required. At Yoyime, our team explains the recommended pathway and costs beforehand.
